Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling
Read More Pharma Industry News CXL Ophthalmics bags $32m for minimally-invasive treatment for keratoconus CXL Ophthalmics (CXLO), an American clinical-stage company, has raised $32 million in a Series A funding round for… byPallavi MadhirajuSeptember 30, 2022